John R. Lever
The roles played by classical and non-classical opioid receptors and their ligands in cancer are reviewed, starting with palliation of pain as the traditional linkage, then summarizing current research topics and clinical trials in cancer imaging and therapy, and concluding with a perspective on future directions for the field.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 